1. India Stocks

  2. •

    Finance

  3. •

    Financial conglomerates
Johnson Pharmacare Limited

Johnson Pharmacare Limited

BBSE:JOHNPHARMA
0.39
INR
0.00
(0.00%)
-1.03EPS
275.00MMarket Cap
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
2026 Y
TTM
Revenue per Share
32.56
- -
- -
- -
- -
0.02
- -
0.14
0.06
0.05
- -
- -
- -
- -
Basic EPS, GAAP
- -
- -
- -
- -
- -
- -
- -
- -
- -
-0.02
- -
-0.01
-1.01
-1.03
Free Cash Flow per Basic Share
0.07
0.15
-0.2
0.19
-0.02
-0.02
- -
-0.02
0.09
-0.01
- -
-0.03
-1.04
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
1.06
1.06
1.06
1.06
1.06
1.06
1.06
1.06
0.96
1.04
1.03
1.02
0.01
- -
Tangible Book Value per Share
1.06
1.06
1.06
1.06
1.06
1.06
1.06
1.06
0.96
1.04
1.03
1.02
0.01
- -
Basic Weighted Avg Shares
550
550
550
550
550
550
550
55
550
550
550
584
552
551
Sales/Revenue/Turnover
17,910
- -
- -
- -
- -
9
- -
8
33
25
- -
- -
- -
- -
Operating Margin (%)
- -
- -
- -
- -
- -
-1.19
- -
0.21
4.13
8.85
- -
- -
- -
- -
Depreciation Expense
- -
1
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Income, GAAP
-1
-1
-1
-1
-1
- -
-1
- -
1
-13
-2
-6
-557
-568
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
- -
26
28.05
- -
- -
- -
- -
- -
Profit Margin (%)
- -
- -
- -
- -
- -
-1.19
- -
0.15
2.96
-51.11
- -
- -
- -
- -
Working Capital
250
34
221
35
43
52
49
49
- -
-10
-11
2
21
- -
LT Debt
6
6
6
6
17
17
6
7
6
19
20
6
214
- -
Total Equity
586
585
584
583
582
582
581
581
582
569
568
562
4
- -
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
0.16
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
0.16
- -
- -
- -
- -
- -
Return on Common Equity (%)
-0.14
-0.13
-0.21
-0.13
-0.11
-0.02
-0.16
- -
0.17
-2.24
-0.35
-1.03
-196.92
- -

Capital Structure

INR

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
ST Debt
- -
- -
- -
LT Borrowings
- -
214
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
550
550
550
Market Capitalization
319
264
275

Working Capital

INR

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
Total Current Assets
- -
23
- -
Cash, Cash Equivalents & STI
- -
1
- -
Accounts Receivable, Net
- -
22
- -
Inventories
- -
- -
- -
Total Current Liabilities
- -
2
- -
Payables & Accruals
- -
- -
- -
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

INR

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
-20.53%
-99.23%
Free Cash Flow
162.86%
441.38%
2,915.74%
Net Income, GAAP
1,675.81%
3,251.88%
9,446.75%
Sales/Revenue/Turnover
- -
- -
- -
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
2027
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
-0.01
-0.01
2026
- -
- -
- -
-1.01
-1.01
2027
-0.02
- -
- -
- -
- -

Quarterly Dividends Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
2027
- -
- -
- -
- -
- -

Company Description

Company Profile APIChatGPT
CEO
Ramanlal Nagjibhai Trivedi
Full Time Employees
4
Sector
Finance
Industry
Financial conglomerates
Address
Shop No. I-460, Fourth Floor Ahmedabad GU India 380015
IPO Date
Jul 18, 2005
Website
johnsonpharmacare.com
Similar Companies
Strategy Inc (NASDAQ:MSTR)
BitMine Immersion Technologies, Inc. (NYSE:BMNR)
Strive, Inc. (NASDAQ:ASST)
Hyperliquid Strategies Inc (NASDAQ:PURR)
Stablecoin Development Corporation (AMEX:SDEV)
Jio Financial Services Limited (NSE:JIOFIN)
Business
Johnson Pharmacare Ltd engages primarily in the manufacture, purchase, sale, and trade of pharmaceutical goods, medicinal products, surgical instruments, contraceptives, and veterinary medicines, alongside providing commercial services including vialling, bottling, and distribution. Founded in 1991 and headquartered in India, the company operates mainly within the domestic Indian pharmaceutical market. Its product portfolio spans pharmaceutical formulations and related healthcare products distributed through retail and institutional channels. In the last two years, Johnson Pharmacare Ltd has focused on reducing its debt to become nearly debt-free and has established a new corporate office to support its operational expansion. The company continues to pursue strategic growth via internal strengthening and corporate governance improvements, although no major acquisitions or alliances were publicly reported recently. It remains listed on the Bombay Stock Exchange under the ticker JOHNPHARMA.BO. Johnson Pharmacare's activities are concentrated on servicing healthcare needs through its diversified pharmaceutical product offerings and commercial trading activities within India.